JMIR mHealth and uHealth

Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing, and domotics for health

Editor-in-Chief:

Lorraine R. Buis, PhD, MSI, Associate Professor, Department of Family Medicine, University of Michigan, USA


Impact Factor 6.2 CiteScore 11.6

JMIR mHealth and uHealth (JMU, ISSN 2291-5222) is a leading peer-reviewed journal and one of the flagship journals of JMIR Publications. JMIR mHealth and uHealth has been published since 2013 and was the first mHealth journal indexed in PubMed. 

JMIR mHealth and uHealth focuses on health and biomedical applications in mobile and tablet computing, pervasive and ubiquitous computing, wearable computing and domotics. 

The journal adheres to rigorous quality standards, involving a rapid and thorough peer-review process, professional copyediting, and professional production of PDF, XHTML, and XML proofs.

Like all JMIR journals, JMIR mHealth and uHealth encourages Open Science principles and strongly encourages the publication of a protocol before data collection. Authors who have published a protocol in JMIR Research Protocols get a discount of 20% on the Article Processing Fee when publishing a subsequent results paper in any JMIR journal.

It is indexed in all major literature indices, including MEDLINEPubMedPubMed CentralScopus, Psycinfo, SCIE, JCR, EBSCO/EBSCO Essentials, DOAJ, GoOA and others.

JMIR mHealth and uHealth received a Journal Impact Factor of 6.2 according to the latest release of the Journal Citation Reports from Clarivate, 2025.

JMIR mHealth and uHealth received a Scopus CiteScore of 11.6 (2024), placing it in the 91st percentile (#13 of 153) as a Q1 journal in the field of Health Informatics. 

Recent Articles

Article Thumbnail
Text-messaging (SMS, WeChat etc)-Based Interventions

China’s diabetes epidemic faces critical gaps in glycemic control, with only 50.1% of treated patients achieving hemoglobin A (HbA) targets in 2021. Conventional interventions struggle with scalability in primary care, particularly for vulnerable populations.

|
Article Thumbnail
Usability of Apps and User Perceptions of mHealth

Mobile health (mHealth) apps are increasingly leveraged to support community health workers (CHWs) in delivering high-quality care, particularly in low- and middle-income countries. However, despite the proliferation of mHealth tools, few have been implemented at scale, partly due to limited attention to usability and acceptability among end users. In sub-Saharan Africa, mHealth tools designed for CHWs often lack systematic evaluation using validated instruments tailored to local contexts. Without such assessments, it is difficult to ensure that these tools can be integrated effectively into CHW workflows and scaled sustainably.

|
Article Thumbnail
Wearables and MHealth Reviews

Good motor performance skills (MPS) are relevant in all stages of life. Higher MPS are associated with enhanced cognitive abilities and physical and mental health. The assessment of MPS is important to identify deficits in MPS at an early stage and to implement interventions to address these deficits. One method to assess MPS is through marker-based motion capture in a laboratory setting with multiple cameras. However, this approach is expensive and time-consuming, making it impractical, for example, in large-scale studies for MPS assessment. Recent advancements (eg, artificial intelligence) in technology (eg, smartphone cameras) have opened up innovative solutions for various challenges (eg, testing large sample sizes). A potential solution is using video-based smartphone apps to assess MPS through markerless motion capture with a single camera.

|
Article Thumbnail
mHealth for Wellness, Behavior Change and Prevention

Goal personalization features integrated into mobile health apps have the potential to enhance physical activity, as some evidence shows that the personalized goals generated by algorithms are more effective than default or fixed goals. However, it remains unclear whether goals set by users are more effective than fixed goals and which personalization strategy is more effective for different user segments.

|
Article Thumbnail
mHealth for Telemedicine and Homecare

Type 2 diabetes mellitus (T2DM) is a prevalent chronic metabolic disorder that poses substantial challenges to global health care systems and patient management. Telemedicine, defined as the use of information and communication technologies to enhance health care delivery, has emerged as a potential tool to improve access to care and facilitate the management of T2DM.

|
Article Thumbnail
Quality Evaluation and Descriptive Analysis/Reviews of Multiple Existing Mobile Apps

As the world’s population ages, the prevalence of chronic low back pain (CLBP) is increasing, placing a substantial burden on individuals and healthcare systems. Mobile health (mHealth) apps offer a potentially scalable solution to support self-management, but little is known about how, why, for whom, and under what circumstances such tools work in real-world settings.

|
Article Thumbnail
Usability of Apps and User Perceptions of mHealth

E-health is an increasingly utilized method of healthcare in the field of psycho-oncology. While many reports highlight the positive impact of psychological e-health tools, there are patients who refuse to use them.

|
Article Thumbnail
Usability of Apps and User Perceptions of mHealth

Mobile health (mHealth) apps have shown promise to support recovery from substance use disorders. However, evidence on engagement and efficacy is still inconclusive.

|
Article Thumbnail
Quality Evaluation and Descriptive Analysis/Reviews of Multiple Existing Mobile Apps

The use of mobile apps in oncology has been expanding rapidly, encompassing prevention, treatment, and patient support. These technologies hold significant potential to improve care delivery and enhance the efficiency of health care services. However, their integration into clinical practice faces important challenges. A key issue lies in the difficulties health care professionals (HCPs) encounter when selecting apps that adequately meet their specific needs and comply with appropriate standards of quality and clinical effectiveness. This lack of robust evidence on the availability, adoption, and evaluation of mobile apps designed for cancer care professionals not only hinders their wider adoption but also restricts their potential to serve as reliable tools in oncology practice.

|
Article Thumbnail
Security and Privacy of mHealth and uHealth

Driven by technological advancements, the proliferation of mobile sports and health applications (apps) has revolutionized health management by improving efficiency, cost-effectiveness, and accessibility. While the widespread adoption of these platforms has transformed public health practices and social well-being in China, emerging evidence suggests that inadequacies in their privacy policies may compromise personal information (PI) protection.

|
Article Thumbnail
Wearables and MHealth Reviews

Wearable devices enable the remote collection of health parameters, supporting the outpatient plans recommended by the World Health Organization (WHO) to manage chronic diseases. While disease-specific monitoring is accurate, a comprehensive analysis of wearables across various chronic diseases helps to standardize remote patient monitoring (RPM) systems.

|
Article Thumbnail
Text-messaging (SMS, WeChat etc)-Based Interventions

Smoking is a leading cause of mortality and morbidity across the global. Efforts to reduce smoking prevalence have used text-message based interventions, which typically send participants a series of short, informational, motivational and practical messages over a set period. Evidence highlights the efficacy of using this approach to support smoking cessation, with such trials typically reporting the average treatment effects, in which causal inference is made regarding the average effect of a treatment on a heterogeneous sample. Nonetheless, using this approach to assessing treatment effects means we are unable to account for individual factors that impact the effectiveness of a treatment on outcomes, such as age, gender, and genetics.

|

Preprints Open for Peer Review

|

Open Peer Review Period:

-

We are working in partnership with